← Evidence map

ArticleAmerican journal of translational research2021

Clinical efficacy and safety of crizotinib and alectinib in ALK-positive non-small cell lung cancer treatment and predictive value of CEA and CA125 for treatment efficacy.

Zhi Li et al.PubMed ↗Full text ↗

No numbers read from the abstract.

11 papers cite it

2021
2022
2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34956530